Ledger.Open graph →

SEC Form D · filed April 9, 2020

CRISPR Therapeutics AG

Offering

$1.0M

Sold

$1.0M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

Zug, V6

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (32)

Lawrence Klein · Zug, V8Exec John Greene · Zug, V8Director Tony Ho · Zug, V8Exec James Kasinger · Zug, V8Exec Michael Tomsicek · Zug, V8Exec Bradley Bolzon · Zug, V8Director Samarth Kulkarni · Zug, V8Exec · Director Simeon George · Zug, V8Director Ali Behbahani · Zug, V8Director Katherine High · Zug, V8Director Trinda A. Blackmore · Grand Cayman, Cayman IslandsDirector Sebastian Caliri · AUSTIN, TXDirector Alexander Harrington · New York, NYDirector Justin C. Valley · Lake Oswego, ORExec Ian Sheridan · Boston, MAExec Burke Wise · NEW YORK, NYDirector Foy H. Tatum · Montgomery, ALExec Henry Russell · Sheridan, WYExec John Reeves · Sheridan, WYDirector Christian Klacko · Boston, MAExec · Director Rodger Novak · Basel, V8Exec · Director D. A. Tatman Ii · NASHVILLE, TNExec Elisa Zhang · Cedar City, UTDirector Ady N. Adefris · Quarry Bay, Hong KongExec · Director Scott Shipman · Vancouver, British Columbia, CanadaExec Justin Butler · San Francisco, CADirector Ying Wang · Mountain View, CAExec Lynne Winings · Cleveland, OHDirector Dan Bergrin · Cleveland, OHDirector Nolan T. Altman · Oceanside Drive, NYDirector Terry Wheeler · ROSEVILLE, CAExec Rodger Novak · Basel, V8Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗